| 英文别名 |
6-Oxo D-(-)-Norgestrel;6-Oxo Norgestrel;(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-2,7,8,9,10,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,6-dione;6-Oxo D-(-)-Norgestr;13-Ethyl-17-hydroxy-18,19-dinorpregn-4-en-20-yne-3,6-dione;6-Keto Levonorgestrel;UNII-UD6T9X38NA;13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yne-3,6-dione;AKOS032958190;Levonorgestrel impurity J [EP];LEVONORGESTREL IMPURITY J [EP IMPURITY];DTXSID40858264;1175109-63-3;6-Oxolevonorgestrel;(8R,9S,10R,13S,14S,17R)-13-Ethyl-17-ethynyl-17-hydroxy-8,9,10,11,12,13,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthrene-3,6(2H,7H)-dione;UD6T9X38NA;Levonorgestrel Impurity J (6-Keto Levonorgestrel);18,19-DINORPREGN-4-EN-20-YNE-3,6-DIONE, 13-ETHYL-17-HYDROXY-, (17.ALPHA.)-;18,19-Dinorpregn-4-en-20-yne-3,6-dione, 13-ethyl-17-hydroxy-, (17alpha)-;13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3,6-dione (6-Oxolevonorgestrel; 6-Ketolevonorgestrel);13-ETHYL-17-HYDROXY-18,19-DINOR-17.ALPHA.-PREGN-4-EN-20-YNE-3,6-DIONE;J-003629 |
